Tag Archives: L’Oreal

Valeant divests assets worth $2.1 billion to ease debt load; finally a smart move, but too little, too late?

Valeant Pharmaceuticals International Inc. (Laval Quebec) is selling its Dendreon cancer treatment business and three skincare brands for $2.12 billion as the troubled Canadian drugmaker looks to reduce more than… Read more »

GSK Surprises Many, Names Emma Walmsley New CEO; Opinion Divided on Witty Legacy

GlaxoSmithKline PLC (London) appointed Emma Walmsley, the head of its consumer business, to become its next CEO. She is the first woman to run a major pharmaceutical giant, according to Forbes…. Read more »